












|
|
FACT Announces New Accreditations;
Accredited Facilities Now Total 151
One blood and marrow transplant program joined the ranks of 150 others that are FACT accredited, and 16 facilities earned accreditation renewals during the first quarter of 2007, according to the Foundation for the Accreditation of Cellular Therapy (FACT).
FACT is a non-profit voluntary foundation for standard-setting, self-assessment, inspection and accreditation in all phases of hematopoietic collection, processing and transplantation. It is jointly sponsored by ASBMT and the International Society for Cellular Therapy (ISCT).
The accreditation actions were:
NEW ACCREDITATIONS
Allogeneic and autologous marrow and peripheral blood progenitor cell transplantation, including collection and laboratory processing:
- Morgan Stanley Children's Hospital of New York-Presbyterian/Columbia University Medical Center (MSCHONY-CUMC), New York, New York
Program Director: Mitchell Cairo, MD
ACCREDITATION RENEWALS
Allogeneic and autologous marrow and peripheral blood progenitor cell transplantation, including collection and laboratory processing:
- Adult Hematopoietic Stem Cell Transplant Program, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, Massachusetts
Program Director: Joseph Antin, MD
- City of Hope Samaritan, Bone Marrow Transplantation Program, Phoenix, Arizona
Program Director: Jeffrey Schriber, MD
- Dana-Farber/Children's Hospital Cancer Care Pediatric Stem Cell Transplantation Program, Boston, Massachusetts
Program Director: Leslie Lehmann, MD
- Massachusetts General Hospital, Bone Marrow Transplant Program, Boston, Massachusetts
Program Director: Thomas Spitzer, MD
- Medical City Dallas Hospital and Medical City Children's Stem Cell Transplanation and Research Program, Dallas, Texas
Program Director: Robert Berryman, MD
- Stanford University Medical Center, Blood and Marrow Transplant Program, Stanford, California
Program Director: Robert Negrin, MD
- The Blood and Marrow Transplant Group of Georgia at Northside Hospital, Atlanta, Georgia
Program Director: Kent Holland, MD
- The Universtiy of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, Texas
Program Director: Richard Champlin, MD
- Tufts-New England Medical Center bone Marrow and Hematopoietic Cell Transplant Program, Boston, Massachusetts
Program Director: Hans Klingemann, MD, PhD
- UMASS Memorial Medical Center Blood and Marrow Transplant Program, Worcester, Massachusetts
Program Director: Ahmad Samer Al-Homsi, MD
- University Hospitals of Cleveland Blood and Marrow Transplant Program, Cleveland, Ohio
Program Director: Hillard Lazarus, MD
- University of Maryland, Greenebaum Cancer Center Blood and Marrow Transplant Program, Baltimore, Maryland
Program Director: Saul Yanovich, MD
Allogeneic and autologous peripheral blood progenitor cell transplantation, including collection and laboratory processing:
- The Cancer Institute of New Jersey, Robert Wood Johnson University Hospital Blood and Marrow Transplant Program, New Brunswick, New Jersey
Program Director: Arnold Rubin, MD
- Yale-New Haven Medical Center, Stem Cell Transplant Program, New Haven, Connecticut
Program Director: Dennis Cooper, MD
Peripheral blood progenitor cell collection and laboratory processing:
- Carter BloodCare, Bedford, Texas
Program Director: Frank Nizzi, DO
Peripheral blood progenitor cell laboratory processing:
- BioCellutions, Memphis, Tennessee
Program Director: Bonni Hazelton, PhD
Currently there are 151 accredited blood and marrow transplant facilities, and 42 additional facilities are in various stages of application and inspection. Thirteen cord blood banks have FACT/NetCord accreditation, and 41 additional banks in 16 countries have applied for accreditation.
For a complete list of accredited facilities and additional information about FACT accreditation, visit the FACT Web site.
|